Payal Bhatt

Payal Bhatt, PharmD, has extensive experience in the pharmaceutical industry, currently serving as a Medical Science Liaison at AbbVie. Previous roles include a Post-Doctoral Fellow in Global Regulatory Strategy and a Post-doctoral Scholar Fellowship Trainee at the University of Southern California. Payal has also worked as a GRACS Quality & Compliance Extern at Merck and as a Medical Outcomes and Value Liaison Extern at Indivior. Notable research projects include studies on Tacrolimus effects on lung transplant rejection rates and the use of convalescent plasma in hospitalized COVID-19 patients. Payal holds a Doctor of Pharmacy (PharmD) from the University of Pittsburgh School of Pharmacy, earned in 2023, and a Bachelor's degree in Pharmaceutical Sciences from the University of Pittsburgh, obtained in 2021.